C1 esterase inhibitor suppresses bradykinin cascade (Figure 1); therefore, its deficiency results in the activation of bradykinin-mediated angioedema, leading to the enhancement of kallikrein production from prokallikrein. This evidence concerns the gene KLK4 and angioedema.